ViiV Healthcare secures FDA approval for Tivicay PD to treat HIV in children
Dolutegravir is an integrase strand transfer inhibitor which, in combination with other antiretroviral agents, has potential to treat…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jun 20
Dolutegravir is an integrase strand transfer inhibitor which, in combination with other antiretroviral agents, has potential to treat…
11 Jun 20
Opdivo is indicated for unresectable advanced, metastatic ESCC after prior fluoropyrimidine- and platinum-based chemotherapy
08 Jun 20
FDA indicated Recarbrio for patients aged 18 years or older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia…
05 Jun 20
Daratumumab SC, administered as a fixed-dose, would reduce treatment time compared to daratumumab intravenous (IV) formulation
04 Jun 20
The regulatory approval is based on the Phase 3 BEACON CRC trial, which showed positive results for BRAFTOVI…
03 Jun 20
Philips’ new patient monitoring solutions will support infection-control protocols and remotely provide critical patient information for caregivers
02 Jun 20
The new indication expands Brilinta treatment to high-risk coronary patients without a history of stroke or heart attack
01 Jun 20
Janssen’s investigational Ebola vaccine regimen leverages its AdVac and PER.C6 technologies and Bavarian Nordic’s MVA-BN technology
01 Jun 20
Tecentriq plus Avastin is the only cancer immunotherapy regimen approved for the treatment of metastatic hepatocellular carcinoma
29 May 20
FDA indicated TAUVID for PET imaging of brain to assess the density and distribution of NFTs in patients…